Acrux
↗Melbourne, Australia
Acrux is a specialty pharmaceutical company focused on developing and commercializing a pipeline of topically applied pharmaceutical products. Utilizing its proprietary transdermal drug delivery technology, the company specializes in creating generic and differentiated topical formulations (creams, gels, and sprays) that are administered through the skin.
The company's business model focuses on the Abbreviated New Drug Application (ANDA) pathway in the United States, targeting high-value generic opportunities. Acrux manages the entire development lifecycle from formulation and analytical development to clinical bioequivalence trials and regulatory submission, typically partnering with established distributors for commercial launch.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Topical Drug Delivery & Generics
SIZE & FINANCIALS
Employees:1-50
Revenue:$10M-$20M AUD
Founded:1998
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:N/A (Publicly Traded)
Investors:Allan Gray Australia, Institutional and Private Investors
STOCK
Exchange:ASX
Ticker:ACR
Market Cap:$25M - $35M AUD
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved/Marketed
Modalities:Small molecule, Topical Gel, Transdermal Spray, Ointment
Active Trials:3
Trial Phases:Phase 3: 3
FDA Approvals:5
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Acrux DDS Pty Ltd, Acrux Pharma Pty Ltd
Key Partnerships:Dash Pharmaceuticals (Commercial partner for Dapsone), Padagis (Commercial partner for multiple generics), TruPharma (Commercial partner for Triamcinolone), Gedeon Richter (Lenzetto distribution)
COMPETITION
Position:Niche Player
Competitors:Mayne Pharma, Taro Pharmaceutical Industries, Perrigo, Bausch Health
LEADERSHIP
Key Executives:
Michael Kotsanis - CEO and Managing Director
Felicia Colagrande - Head of Quality
Scientific Founders:Professor Barrie Finnin, Professor David Morgan
Board Members:Ross Dobinson (Non-Executive Chairman), Don Brumley, Dr. Geoff Brooke
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Acrux. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.